Thanks to visit codestin.com
Credit goes to www.scribd.com

0% found this document useful (0 votes)
10 views30 pages

Lecture 2

Uploaded by

majd dan
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
10 views30 pages

Lecture 2

Uploaded by

majd dan
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 30

Definitions

Glomerular diseases are the pathological processes most often (but


not always) found on native renal biopsy (Ch. Jennette 2007).

Classification of glomerular disease


Non inflammatory glomerular diseases
•Inherited
•Acquired
• drug induced,
• metabolic diseases (Amyloidosis, DM, MIDD,)
• vascular – HT, pre eclampsia other
Inflammatory glomerular diseases (glomerulonephritis) classified
according to KB
Clinical
•Acute
•Rapid progressive
•Chronic
SIGNS & SYNDROMES
MINIMAL
NEPHROTIC NEPHRITIC URINARY
SYNDROME SYNDROME ANOMALIES

PRIMARY - GN - SECONDARY

MCD MPGN FSGS MGN MPGN


ACUTE
GLOMERULONEPHRITIS
DEFINITION
Acute glomerular inflammatory disease of several etiologies

Common clinical characteristics


• frequently associated to an infection
• clinical signs preceded by variable period free of symptoms
• sudden onset with nephritic syndrome ( hypertension, hematuria, proteinuria and
edema)
• frequently - diminished GFR
• frequently good outcome
ETIOLOGY
ACUTE PRIMARY GN
• Mez Prol GN,
• IgA GN,
• Mez Cap prol GN,
• RPGN

ACUTE SECONDARY GN
1. INFECTIOUS DISEASES
• Bacterial - streptococcus, staphylococcus, pneumococcus, meningococcus
– less frequently -brucellosis, leptospirosis
• Viral : Coxackie, ECHO, HBV, HCV, varicella, Epstein-Barr, etc
• Protozoa - toxoplasma, plasmodium falciparum, hystoplasma
• Parasitic infestations - trichinella
ETIOLOGY

2. SYSTEMIC DISEASES
• SLE, polyarteritis, Wegener granulomatosis, Goodpasture syndrome,
Henoch-Schonlein purpura, HUS, thrombotic trombocytopenic purpura,
mixed cryoglobulinemia,

3. IMMUNOTHERAPY AND SEROTHERAPY


• Corine bacterium, BCG
• different serotherapies
ETIOLOGY
• Group A, β hemolytic streptococcus
- the nephritogenic and mixed types
- most frequently - type 12
• Group C streptococci - rarely

Site of infection
• throat
• teeth
• skin
PATHOGENESIS
• IMMUNE
• Unknown antigen:
• endostreptosin – evidenced in the mesangium on KB- by
Lange
• cationic proteinase
• extra cellular streptococcal antigens – evidenced in
immune complexes
• Mechanisms :
• CIC - CIC elevated in most patients
- subendotelial IgG and C3 deposits
• In situ IC - cationic antigen captured in GBM
Crioglobuline – have been identified sometimes
PATHOGENESIS
GBM

Endo Epi
ATG
Autoimmune mechanisms: anti colagen,
IC anti-laminin, anti-HS, anti-reumathoid
factor
ATB
Immune effectors
• Chemotactism
Humps • PMNL • Phagocytes

Endo • Cytokines • GBM lesions


ATG • Inflammation
• Complement
• Proliferation

ATB

Humps
PATHOLOGY
Light microscopy
- Exudative lesions – PMNL, M, Eo
- Endocapillary proliferation (endothelial and mesangial)
- Sub epithelial eozinophile deposits
Immunofluorescence
- C3 +/- IgG deposits: finely granular (in the capillary walls),
lumpy ( in the mesangium), garland pattern (which outline the
capillary wall)
Electron microscopy
- Sub epithelial electron-dense deposits (humps)
PATHOLOGY
PATHOLOGY

C3 +/-IgG finely
granular deposits
“starry sky”
PATHOLOGY

Hump
Clinical signs in 3 periods:
CLINICAL SIGNS • Streptococci infection,
• No clin signs,
INCIDENCE • The acute nephritis
• Affects children more than adults
• Male/female ratio 4/1 – 10/1
• Seldom recorded after the age of 50

1 – THE STREPTOCOCCI INFECTION


a.) Sub-clinical or non-symptomatic infection
b.) Symptomatic infection
- site of infection - pharyngitis, intertrigo, dental abscesses
Clinical signs in 3
CLINICAL SIGNS periods:
• Streptococci infection,
• No clin signs,
• The acute nephritis
2. NO CLIN. SIGNS
- 7 – 21 days (after pharyngitis); 3 – 6 weeks (after intertrigo)
- free of symptoms
- seldom – mild proteinuria or microhematuria

The absence of the latent period or a latent period shorter


than 7 days suggests the idea that the AGN is not a post
streptococcal GN
Clinical signs in 3
CLINICAL SIGNS periods (steps):
3. THE ACUTE NEPHRITIS • Streptococci infection,
Nephritic Syndrome • Latent period,
•Hypertension • The acute nephritis
•Nephritic proteinuria - <3.5g/24h
•Hematuria microscopic or macroscopic
•Edema induced by salt and fluid overload
•(+/-)
• Oliguria – in the edema formation period
• Diffuse bilateral back pain
• Acute renal failure
LAB

• Inflammatory syndrome
- Increased ESR,
- Elevated levels of CRP and fibrinogen
- Elevated Fibrin Degradation Products in urine and serum

• Urinary syndrome
- proteinuria usually non-nephrotic (<3,5g/24h)
- casts – hematic and hyaline
- hematuria - microscopic or gross hematuria
> 80% dysmorphic erythrocytes
LAB

• Immune disorders
- Increased CIC levels
- Low C3 levels
- Decreased hemolytic activity of CH50
Sometimes – RF- present in the serum
- Urinary crioglobuline - present
LAB

• Streptococcal infection profile


- ASO titers - increase at 3 weeks time from the streptococcal
infection and normalizes in 6 months
– In cutaneous infection sites anti hyaluronidase, anti DNA
polymerase B ATB ( strains that do not synthesize SLO ? )
- anti streptozim ATB
- anti cationic proteinase ATB
- anti protein M ATB
LAB
Kidney function
• GFR (CKD Epi)
• RPF usually normal
• Concentrating ability preserved

IMAGISTICS
• Enlarged kidneys – Renal plain X ray, intravenous
pyelography, renal ultrasound
DIAGNOSIS

1. No history of glomerular disease


2. Recent streptococcal infection
3. Latent period > 7 days
4. Sudden onset with acute nephritic syndrome
LAB
1. Inflammatory syndrome
2. Immune disorders – elevated CIC , decreased C3 levels
3. Evidence for streptococci infection
4. Bilateral enlarged kidneys
5. Absence of a systemic disease
6. KB – proliferative endocapillary GN
KIDNEY BIOPSY only if:

1. Acute GN with oliguria or anuria


2. Elevated BUN and serum creatinine which persists >4 weeks
3. Persistent hypertension > 4 weeks
4. Proteinuria > 3,5g% persisting > 4 weeks
5. Decreased C3 levels persisting > 8 weeks
DIFFERENTIAL
DIAGNOSIS
Acute GN – Acute PN
- Signs and symptoms – NO EDEMA, NO HT
- leucocyturia > hematuria, hematuria with eumorphic erythrocytes
- NO SIGNS for streptococci infection

Acute GN – Chronic GN
- History for glomerular disease ( HT, Proteinuria, Edema, Hematuria )
- Latent period less than 7 days
- Bilateral small kidneys
DIFFERENTIAL
DIAGNOSIS
The etiology of acute GN
1. Secondary GN
- LES
- H-S purpura
- Bacterial endocarditis
- Vasculitis
1. Primary GN
- IgA GN
- RPGN
CLINICAL FORMS
1. The common type- acute nephritic syndrome
2. The type without renal signs (hematuria proteinuria)–
HT+ edema
3. Monosymptomatic forms –
4. The form with nephrotic syndrome
5. The form with AKI

COMPLICATIONS
1. Renal – AKI
2. Cardiac and vascular – APE, cerebral edema,
hypertensive encephalopathy and stroke, congestive
heart failure
3. Infectious – UTI, respiratory infections
OUTCOME

1. Overall prognosis – very good – healing - 1 year - 70 – 80%


of the children, 50 – 60% adults
2. Evolution to chronic GN – after 1 year from the onset
3. Rarely - RPGN
TREATMENT
1. Prophylactic treatment
- The prophylaxis of the streptococci infection
1. Cure of infection
- Penicillin G 400.000iu/6h IM - 14-21 days followed by
Slow release penicillin 1 200 000 iu/10 days IM – during
6-12 months
- Eritromicine, Roxitromicine, Clartitromicine
1. Diet
- bed rest until edema remission
- hyponatremic - 4g NaCl/day

- low protein intake 0,4 – 0.6g/kg/day – if AKI occurs


TREATMENT
1. Removal of infectious foci
- at least at 3 months after the onset of the disease
1. Treatment of the symptoms
- Edema – Loop diuretics – Furosemid, Torasemid , Bumetanide
- HT –
- ACEI – Perindopril 10mg/day (if no AKI) – eny other
- Ca Ch B – Amlodipine 10mg/day, Lecarnidipine 10mg/day
- Clonidin 3 x 0,15mg/day

- Treatment of the complications


DO NOT
- Vaccinate – first 2 years after healing of APGN
- Administer corticotherapy
- exception : RPGN, ARF

You might also like